Veterinary Ophthalmic & Dermatologic Products Market
完整報告名稱與涵蓋範圍
Veterinary Ophthalmic & Dermatologic Products Market Size, Share & Trends Analysis Report, By Product Category (Ophthalmic Anti-Inflammatory, Anti-Infective and Lubricant Products, Ophthalmic Glaucoma and Specialty Therapeutics, Dermatologic Anti-Pruritic and Allergy Therapeutics, Dermatologic Anti-Infective, Antifungal and Otic Products, Medicated Shampoos, Topicals and Skin Barrier Products), By Animal Type (Dogs, Cats, Horses and Other Animals), By Drug Modality (Small Molecules, Monoclonal Antibodies and Biologics, Topical and OTC Formulations), By Distribution Channel, By Region, and Segment Forecasts, 2026-2035
報告摘要
The veterinary ophthalmic and dermatologic products market covers prescription and clinic-channel medicines for eye and skin conditions in companion animals and horses, including ophthalmic anti-inflammatory, anti-infective, lubricant and glaucoma products, dermatologic anti-pruritic, allergy, anti-infective, antifungal and otic therapeutics and medicated shampoos and topical barrier products. Human ophthalmic products used off-label without veterinary labelling and general parasiticides are excluded.
Dermatology is the most frequent reason for veterinary visits, and the launch of targeted anti-pruritic small molecules and monoclonal antibodies for canine atopic dermatitis transformed a category once dominated by corticosteroids into a multi-billion-dollar franchise with feline extensions in development. Ophthalmology is smaller but growing with dry eye, glaucoma and infection therapies formulated for animals and with increased referral to veterinary ophthalmologists. Growth is supported by pet humanisation, insurance uptake and chronic disease management, while generic entry for early targeted molecules, otic formulation innovation and microbiome-based skin care shape competitive activity.
North America and Europe generate most revenue, with Asia Pacific and Latin America growing through expanding companion animal care. Competition involves animal health leaders with dermatology franchises, dermatology and otic specialists and dermo-cosmetic companies serving the veterinary channel.
The InsightAce study supplies US$ forecasts for all product category, animal type, drug modality and distribution channel and regional segments over 2026-2035, segment-level trend analysis, competitive landscape assessment and profiling of the leading companies.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Ophthalmic & Dermatologic Products Market Snapshot
Chapter 4. Global Veterinary Ophthalmic & Dermatologic Products Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Category Estimates & Trend Analysis
5.1. Product Category & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Category:
5.2.1. Ophthalmic Anti-Inflammatory, Anti-Infective and Lubricant Products
5.2.2. Ophthalmic Glaucoma and Specialty Therapeutics
5.2.3. Dermatologic Anti-Pruritic and Allergy Therapeutics
5.2.4. Dermatologic Anti-Infective, Antifungal and Otic Products
5.2.5. Medicated Shampoos, Topicals and Skin Barrier Products
Chapter 6. Market Segmentation 2: By Animal Type Estimates & Trend Analysis
6.1. Animal Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Animal Type:
6.2.1. Dogs
6.2.2. Cats
6.2.3. Horses and Other Animals
Chapter 7. Market Segmentation 3: By Drug Modality Estimates & Trend Analysis
7.1. Drug Modality & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Drug Modality:
7.2.1. Small Molecules
7.2.2. Monoclonal Antibodies and Biologics
7.2.3. Topical and OTC Formulations
Chapter 8. Market Segmentation 4: By Distribution Channel Estimates & Trend Analysis
8.1. Distribution Channel & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
8.2.1. Veterinary Clinics and Specialty Hospitals
8.2.2. Retail and E-Commerce Pharmacies
Chapter 9. Veterinary Ophthalmic & Dermatologic Products Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Zoetis Inc.
11.2. Elanco Animal Health Incorporated
11.3. Dechra Pharmaceuticals PLC
11.4. Virbac S.A.
11.5. Ceva Sante Animale
11.6. Bayer Animal Health (Elanco)
11.7. Vetoquinol S.A.
11.8. Boehringer Ingelheim Animal Health
11.9. Merck Animal Health (MSD Animal Health)
11.10. Bimeda Holdings
11.11. Dermoscent (Laboratoire de Dermo-Cosmetique Animale)
11.12. Douxo (Ceva)
11.13. An-Vision GmbH
11.14. Kane Biotech Inc.
11.15. Piedmont Animal Health
圖表清單 List of Tables & Figures
Table 1. Global Veterinary Ophthalmic & Dermatologic Products Revenue Forecast by Product Category, 2026-2035 (US$ Mn)
Figure 1. Global Veterinary Ophthalmic & Dermatologic Products Market Snapshot, 2026 & 2035
Table 2. Global Veterinary Ophthalmic & Dermatologic Products Revenue Forecast by Animal Type, 2026-2035 (US$ Mn)
Figure 2. Global Veterinary Ophthalmic & Dermatologic Products Market Share by Animal Type, 2026 & 2035
Table 3. Global Veterinary Ophthalmic & Dermatologic Products Revenue Forecast by Drug Modality, 2026-2035 (US$ Mn)
Figure 3. Canine Atopic Dermatitis Treatment Paradigm from Corticosteroids to Targeted Biologics
Table 4. Global Veterinary Ophthalmic & Dermatologic Products Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 4. Veterinary Ophthalmic Product Landscape by Indication and Formulation
Table 5. North America Veterinary Ophthalmic & Dermatologic Products Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Veterinary Ophthalmic & Dermatologic Products Growth Opportunity Analysis
Table 6. Europe Veterinary Ophthalmic & Dermatologic Products Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Generic Entry Timeline for Targeted Dermatology Molecules and Its Revenue Impact
Table 7. Asia Pacific Veterinary Ophthalmic & Dermatologic Products Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key Veterinary Ophthalmic & Dermatologic Products Market Participants
Table 8. Latin America and Middle East & Africa Veterinary Ophthalmic & Dermatologic Products Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們